32 research outputs found
Spontaneous expulsion from rectum: a rare presentation of intestinal lipomas
Lipomas are rare, subserosal, usually solitary, pedunculated small lesions appearing mainly in the large intestine with a minimal malignancy potential. They usually run asymptomatic and become symptomatic when they become enlarged or complicated causing intestinal obstruction, perforation, intusucception or massive bleeding. In rare cases they can be self-detached and expulsed via the rectum as fleshy masses. This event mainly occurs in large, pendunculated lipomas which detach from their pedicle. The reason for this event remains in most of cases unclear although in some cases a predisposing factor does exist. Abdominal pain and obstructive ileus may be observed while in many cases bleeding occurs. The expulsed mass sets the diagnosis and in most of the cases all symptoms subside. Diagnosis is rarely established before surgery with the use of barium enema, computed tomography and colonoscopy which additionally provides measures of treatment and diagnosis. In atypical cases though, in cases where the malignancy can not be excluded or in complicated cases, surgery is recommended. Usually the resection of the affected intestinal part is adequate. If during surgery a lipoma is encountered simple lipomatectomy seems also to be adequate
The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders
Background. We conducted a study in order to determine the usefulness and diagnostic value of International Autoimmune Hepatitis Group (IAHG) score in non-autoimmune hepatitis (AIH) hepatic disorders as well as in AIH/overlap syndromes and in cases with coexistence of AIH and other liver diseases. Methods. We applied the IAHG score in 423 patients with liver diseases excluding patients with AIH, AIH/overlap syndromes and AIH with concurrent other liver disease namely, patients with chronic hepatitis B (n = 109), chronic hepatitis C (n = 95), chronic hepatitis D (n = 4), alchoholic liver disease (n = 28), non-alcoholic fatty liver disease (n = 55), autoimmune cholestatic liver diseases (n = 77), liver disorders of undefined origin (n = 32) and with miscellaneous hepatic disorders (n = 23). 24 patients with AIH associated with any kind of liver disorder including 10 patients with AIH/overlap syndromes and 14 AIH with concurrent other liver disease were also investigated. 43 patients with AIH consisted the control group. Results. The specificity of the score was 98.1% while the sensitivity in unmasking AIH in patients with either AIH/overlap syndromes or AIH with concurrent other liver diseases was only 50% and 78.6%. In the binary logistic regression model, the presence of other autoimmune diseases (p < 0.001), the total histological score (p < 0.001) and positivity for autoantibodies (p < 0.05) were identified as independent predictors for the presnce of AIH/ovea syndromes o AI with concurren other liver diseass. Conclusion. The IAHG scoring system has very good specificity for excluding AIH in patients with chronic liver diseases but not that sensitivity in order to unmask AIH/overlap syndromes or AIH with concurrent other liver diseases. The presence of other autoimmune diseases or autoantibody markers in the absence of hepatitis viral markers should alarm physicians for the possible presence of AIH either as "pure" AIH or in association with other liver disorders (AIH/overlap syndromes or AIH with concurrent other liver diseases). Under these conditions, liver histology seems essential and it must always be included in the work up of hepatic patients. © 2007 Papamichalis et al; licensee BioMed Central Ltd
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
Background Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide.Methods A multimethods analysis was performed as part of the GlobalSurg 3 study-a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital.Findings Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3.85 [95% CI 2.58-5.75]; p<0.0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63.0% vs 82.7%; OR 0.35 [0.23-0.53]; p<0.0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer.Interpretation Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised
Expression of Angiopoietin, GA733-1 / -2 and CEA genes in patients with colorectal genes
The colo-rectal cancer is the fourth most common type of cancer in both the male and the female population and the second cause of death from cancer in the US. In recent years, however, there is a significant reduction of disease effect. This reduction in disease mortality is a result of progress in the prevention and early detection of cancer through preventive tests and improved therapeutic agents available to physicians. Colorectal cancer is a heterogeneous disease with a different therapeutic strategy for each patient. This strategy is determined by the stage of the disease and the biology of the tumor. The evolution of the molecular study of the carcinogenesis has greatly helped in understanding the genetic nature of colorectal cancer, although there are still many to be done. This study is focused on the genetic basis of colorectal cancer by analyzing 40 patients with colorectal cancer. DNA was isolated from the peripheral blood of these patients as well as RNA from tumor cells and from cells of non-diseased intestinal mucosa from adjacent positions in order to clarify the expression of the genes in normal and in pathological tissue of the intestinal mucosa. This was followed by quantitative reaction of the Polymerase chain reaction-reverse transcription (q-RT-PCR) to determine the expression of the GA733-1, GA733-2, CEACAM5, Ang-1 and Ang-2 genes. These results were then correlated with clinicopathological features of the patients. The expression of the GA733-1gene was almost undetectable in both noncancerous mucosal tissue and cancerous tissue, while the expression of the GA733-2 gene was detectable in all samples. The mean value of GA733-2/h-PBGD mRNA was 273.31 (65.24-1,486.41) and 115.64 (11.58-1-189.14) in noncancerous and cancerous tissue, respectively (p=0.0000195). Significant correlations were found between the GA733-2 gene expression and the stage N of the disease (p=0,0343) as well as with the presence or absence of lymph node infiltration (p=0,008668). The expression of the CEACAM5 gene was detected in all samples with mean value CEACAM5/h-PBGD mRNA: 326,36 (11,97-3.3562,61) and 317,60 (3,37 to 8.896,42) in the non-cancerous and cancerous tissue. A significant correlation was detected between the expression of CEACAM5 gene and the degree of tumor cell differentiation (p=0.0465). The levels of carcino embryonic antigen in human serum were assessed in more than 50% of the samples. The mean value of CEA levels in peripheral serum was 6,5715 (0,86-24,95), while a correlation of CEACAM5 gene and their levels in the peripheral blood was not detected in cancerous cells. Finally, Ang-1 and Ang-2 genes are expressed in all analyzed samples. The mean value of Ang-1/h-PBGD mRNA was 3,6248 (0,0530-16,5433) and 0,9373 (0,0002-11,2039) in the non-cancerous and cancerous tissue, respectively. Concerning the expression of Ang-2, the mean value of Ang-2/h-PBGD gene was 0,7492 (0,0012-5,3992) in noncancerous tissue and 1,4122 (0,0020-0,9665) in cancerous tissue. Significant correlations were observed between the expression of Ang-1 gene and the T stage of the tumor (p=0.04536) as well as Ang-2 gene expression and the tumor cell differentiation grade (p=0.0049). Moreover, the expression level of Ang-1/Ang-2 genes was correlated with the T phase of the tumor (p=0.0364) and the presence of lymph node (N) according to the TNM staging system (p=0.0363).In conclusion, the extremely low levels of the GA733-1 gene detected in our samples was in accordance with the knowledge for the expression of this gene only in colorectal cancer with liver metastasis; the levels of GA733-2 mRNA transcripts were significantly correlated with the N stage of disease as well as with the presence or absence of lymph node infiltration. The increased expression of CEACAM5 gene might be related to the tumor cell differentiation grade, while it was not detected any correlation between the expression of CEACAM5 in cancer cells and its level in peripheral blood. Concerning the expression of Ang-1 and Ang-2 genes, it is evident that as the T phase of the tumor is increased the expression of Ang-1 is reduced, while the low levels of Ang-2 gene were observed in low-grade tumor cells differentiation. Finally, the diversification of the expression of the two angiopoietins in the tumor tissue was correlated with the T stage of the tumor as well as with the presence of lymph node metastasis (N). These results suggest that a better understanding of colorectal cancer biology will significantly contribute to a more rational and effective treatment of the disease.Ο κολο-ορθικός καρκίνος αποτελεί τον τέταρτο πιο συχνό τύπο καρκίνου τόσο στον αντρικό όσο και στο γυναικείο πληθυσμό και τη δεύτερη αιτία θανάτου από καρκίνο στις ΗΠΑ. Τα τελευταία χρόνια όμως παρατηρείται σημαντική μείωση της επίπτωσης της νόσου. Η μείωση αυτή της θνητότητας της νόσου είναι απόρροια της προόδου στην πρόληψη και στην έγκαιρη διάγνωση του καρκίνου μέσω των προληπτικών ελέγχων, της καλύτερης διάγνωσης και της βελτίωσης των θεραπευτικών μέσων που διατίθενται. Ο κολο-ορθικός καρκίνος είναι μία ετερογενής νόσος με διαφορετική θεραπευτική στρατηγική για τον κάθε ασθενή που καθορίζεται από το στάδιο της νόσου και τη βιολογία του όγκου. Η εξέλιξη της μελέτης της μοριακής βάσης της καρκινογένεσης έχει βοηθήσει σημαντικά την κατανόηση της γενετικής φύσης του κολο-ορθικού καρκίνου, αν και υπάρχουν ακόμα πολλά προς διερεύνηση.Η παρούσα διδακτορική διατριβή εστιάστηκε στη μελέτη της γενετικής βάσης του κολο-ορθικού καρκίνου μελετώντας 40 ασθενείς με κολο-ορθικό καρκίνο, από τους οποίους απομονώθηκε γενετικό υλικό τόσο από τα καρκινικά κύτταρα του όγκου όσο και από κύτταρα του μη νοσούντος εντερικού βλεννογόνου από παρακείμενες θέσεις προκειμένου να παρατηρήσουμε την έκφραση γονιδίων στο φυσιολογικό και παθολογικό ιστό του εντερικού βλεννογόνου. Στη συνέχεια ακολούθησε ποσοτική αντίδραση αλυσιδωτής αντίδρασης Πολυμεράσης-αντίστροφης μεταγραφής (q-RT-PCR) για τον προσδιορισμό της ποσοτικής έκφρασης των γονιδίων GA733-1, GΑ733-2, CEACAM5, Ang-1 και Ang-2. Τα αποτελέσματα αυτά συσχετίστηκαν στη συνέχεια με τα κλινικοπαθολογικά χαρακτηριστικά των ασθενών. Η έκφραση του γονιδίου GA733-1 ήταν πολύ χαμηλή έως μη ανιχνεύσιμη τόσο στο μη καρκινικό βλεννογονικό ιστό όσο και στον καρκινικό. Η έκφραση του γονιδίου GA733-2 ήταν ανιχνεύσιμη σε όλα τα δείγματα και η μέση τιμή GA733-2/h-PBGD ήταν 273,31 (65.24-1,486.41) και 115,64 (11.58-1-189.14???) στο μη καρκινικό και καρκινικό ιστό, αντιστοίχως (p = 0.0000195). Στατιστικώς σημαντικές συσχετίσεις εντοπίστηκαν μεταξύ της έκφρασης του γονιδίου GA733-2 και το στάδιο Ν της νόσου (p = 0,0343) και με την παρουσία ή μη λεμφαδενικής διήθησης (p=0,008668). Η έκφραση του CEACAM5 γονιδίου στον ιστό ήταν ανιχνεύσιμη σε όλα τα δείγματα με μέση τιμή CEACAM5/h-PBGD mRNA: 326,36 (11,97-3.3562,61) στο μη καρκινικό ιστό, ενώ στον καρκινικό ιστό η μέση τιμή CEACAM5/h-PBGD mRNA ήταν 317,60 (3.37 έως 8896.42). Σημαντική συσχέτιση εντοπίστηκε μεταξύ της έκφρασης του CEACAM5 γονιδίου και του βαθμού διαφοροποίησης των καρκινικών κυττάρων (p=0.0465). Τα επίπεδα του καρκινο-εμβρυϊκού αντιγόνου στον ανθρώπινο ορό αξιολογήθηκε σε περισσότερους από το 50% των δειγμάτων. Η μέση τιμή των επιπέδων του CEA στο περιφερικό ορό ήταν 6,5715 (0,86-24,95), ενώ δεν εντοπίστηκε κάποια συσχέτιση της έκφρασης του CEACAM5 στα καρκινικά κύτταρα και των επιπέδων τους στο περιφερικό αίμα. Τέλος, τα γονίδια Ang-1 και Ang-2 εκφράζονται σε όλα τα υπό μελέτη δείγματα. Η μέση τιμή έκφρασης Ang-1/h-PBGD ήταν 3,6248 (0,0530-16,5433) και 0,9373 (0,0002-11,2039) στο μη καρκινικό και καρκινικό ιστό, αντιστοίχως. Ως προς την έκφραση του γονιδίου Ang-2, η μέση τιμή Ang-2/h-PBGD ήταν 0,7492 (0,0012-5,3992) στο μη καρκινικό ιστό και 1,4122 (0,0020-10,9665) στον καρκινικό ιστό. Παρατηρήθηκαν σημαντικές συσχετίσεις μεταξύ της έκφρασης του γονιδίου Ang-1 και του σταδίου Τ του όγκου (p=0.04536) καθώς και του γονιδίου Ang-2 και του βαθμού διαφοροποίησης των καρκινικών κυττάρων (p=0.0049). Αναλύοντας τα αποτελέσματά μας προέκυψε συσχέτιση μεταξύ των επιπέδων έκφρασης των γονιδίων Ang-1/Ang-2 και του σταδίου Τ του όγκου (p= 0.0364) καθώς και με την παρουσία λεμφαδενικών μεταστάσεων (Ν) σύμφωνα με το σύστημα σταδιοποίησης κατά ΤΝΜ (p= 0.0363).Συμπερασματικά, η έκφραση του γονιδίου GA733-1 συσχετίστηκε με την ανάπτυξη ηπατικών μεταστάσεων και του GA733-2 γονιδίου με το στάδιο Ν της νόσου. Η αυξημένη έκφραση του CEACAM5 γονιδίου πιθανόν να εμπλέκεται στο βαθμό διαφοροποίησης των καρκινικών κυττάρων, ενώ δεν εντοπίστηκε κάποια συσχέτιση μεταξύ της έκφρασης του CEACAM5 στα καρκινικά κύτταρα και των επιπέδων του στο περιφερικό αίμα. Ως προς την έκφραση των γονιδίων Ang-1 και Ang-2 προέκυψε ότι όσο αυξάνεται το στάδιο Τ του όγκου τόσο μειώνεται η έκφραση της Ang-1, ενώ η μειωμένη έκφραση της Ang-2 παρατηρήθηκε στα χαμηλού βαθμού διαφοροποίησης καρκινικά κύτταρα. Τέλος, η διαφοροποίηση της έκφρασης των δύο αγγειοποιητινών στον καρκινικό ιστό συσχετίστηκε με το στάδιο Τ του όγκου (p= 0.0364) καθώς επίσης και με την παρουσία λεμφαδενικών μεταστάσεων (Ν). Τα αποτελέσματα αυτά υποδεικνύουν ότι η καλύτερη κατανόηση της βιολογίας του κολο-ορθικό καρκίνου θα συμβάλει σημαντικά στην ορθολογικότερη και αποτελεσματικότερη θεραπεία της ασθένειας
Diaphragmatic rupture causing repeated vomiting in a combined abdominal and head injury patient: a case report and review of the literature
<p>Abstract</p> <p>Background</p> <p>Diaphragmatic rupture after blunt abdominal injury is a rare trauma condition. Delayed diagnosis is not uncommon especially in the emergency room setting. Associated injuries often shift diagnosis and treatment priorities towards other more life-threatening conditions.</p> <p>Case presentation</p> <p>We present a challenging case of a young male with combined abdominal and head trauma. Repeated episodes of vomiting dominated on clinical presentation that in the presence of a deep scalp laceration and facial bruising shifted differential diagnosis towards a traumatic brain injury. However, a computed tomography scan of the brain ruled out any intracranial pathology. Finally, a more meticulous investigation with additional imaging studies confirmed the presence of diaphragmatic rupture that justified the clinical symptoms.</p> <p>Conclusions</p> <p>The combination of diaphragmatic rupture with head injury creates a challenging trauma scenario. Increased level of suspicion is essential in order to diagnose timely diaphragmatic rupture in multiple trauma patients.</p
Determination of Factors Related to the Reversal and Perioperative Outcomes of Defunctioning Ileostomies in Patients Undergoing Rectal Cancer Surgery: A Regression Analysis Model
Purpose: Defunctioning ileostomies are often performed during rectal cancer surgery. However, stomas are sometimes associated with complications, while 20–30% of them are never reversed. Additionally, ileostomy closure can have associated morbidity, with rates as high as 45%, with the respective literature evidence being scarce and conflicting. Thus, we evaluated the stoma reversal outcomes and the risk factors for non-closure after rectal cancer surgery. Methods: This is a retrospective analysis of a prospectively collected database of all patients who had a defunctioning ileostomy at the time of resection for rectal cancer. All operations were performed by the same surgical team. A multivariable regression model was implemented. Results: In this study, 129 patients (male: 68.2%, female: 31.8%) were included. Ileostomy formation was associated with a total of 31% complication rate. Eventually 73.6% of the stomas were reversed at a mean time to closure of 26.6 weeks, with a morbidity of 13.7%. Non-reversal of ileostomy was correlated with neoadjuvant CRT (OR: 0.093, 95% CI: 0.012–0.735), anastomotic leakage (OR: 0.107, 95% CI: 0.019–0.610), and lymph node yield (OR: 0.946, 95% CI: 0.897–0.998). Time to reversal was affected by the N status, the LNR, the need for adjuvant chemotherapy, and the histologic grade. Conclusion: In patients with rectal cancer resections, defunctioning stoma closure rate and time to closure were associated with several perioperative and pathological outcomes. © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature
Laparoscopic Versus Open Right Colectomy for Cancer in the Era of Complete Mesocolic Excision with Central Vascular Ligation: Pathology and Short-Term Outcomes
Background: Colectomies performed according to complete mesocolic excision with central vascular ligation (CME-CVL) principles have been associated with enhanced oncologic outcomes. Nonetheless, laparoscopic CME-CVL right hemicolectomy has not been widely adopted. We aimed to compare the perioperative and pathology outcomes of laparoscopic and open CME-CVL right hemicolectomy. Materials and Methods: We compared data from a prospectively collected database regarding patients who underwent either laparoscopic or open CME-CVL right hemicolectomy for nonmetastatic right colon cancer in a University Hospital, between January 2012 and December 2018. Results: A total of 130 consecutive patients were included in the study. Of them, 73 patients underwent laparoscopic and 57 patients open right colectomy, following the CME-CVL principles. The laparoscopic approach was associated with less hospital stay (6.6 versus 9.1 days; P .05), rate of vascular (P = .501), and perineural infiltration (P = .956). Furthermore, no difference was found regarding the rate of intact mesocolic plane (P = .799), along with the tumor diameter (P = .154) and the length of specimen (P = .163). Conclusion: Laparoscopic CME-CVL right hemicolectomy appears to offer certain advantages in short-term outcomes compared to open procedure. Pathology outcomes did not differ between the two approaches. Future studies should further evaluate their long-term outcomes. © Copyright 2021, Mary Ann Liebert, Inc., publishers 2021
Ingested Fish Bone: An Unusual Mechanism of Duodenal Perforation and Pancreatic Trauma
Ingestion of gastrointestinal foreign bodies represents a challenging clinical scenario. Increased morbidity is the price for the delayed diagnosis of complications and timely treatment. We present a case of 57-year-old female patient which was admitted in the emergency room department complaining of a mid-epigastric pain over the last twenty-four hours. Based on the patient's history, physical examination and elevated serum amylase levels, a false diagnosis of pancreatitis, was initially adopted. However, a CT scan confirmed the presence of a radiopaque foreign body in the pancreatic head and the presence of air bubbles outside the intestinal lumen. The patient was unaware of the ingestion of the foreign body. At laparotomy, after an oblique duodenotomy, a fish bone pinned in the pancreatic head after the penetration of the medial aspect of the second portion of the duodenal wall was identified and successfully removed. The patient had an uneventful postoperative recovery. Wide variation in clinical presentation characterizes the complicated fish bone ingestions. The strategically located site of penetration in the visceral wall is responsible for the often extraordinary gastrointestinal tract injury patterns. Increased level of suspicion is of paramount importance for the timely diagnosis and treatment
A meta-analysis of laparoscopic versus open left lateral hepatic sectionectomy
Background: This study aimed to assess the perioperative outcomes of laparoscopic left lateral sectionectomy (LLLS) compared with an open (OLLS) approach. Method: A systematic literature search was performed in PubMed, Scopus and Cochrane library, in accordance with the PRISMA guidelines. The Odds Ratio (ORs), the weighted mean difference (WMD) and 95% confidence interval (95% CI) were evaluated, by means of Random-Effects model. Results: Ten articles met the inclusion criteria and incorporated 2640 patients. This study reveals comparable mean operative time, mean operative margin size and rate of R1 resection between LLLS and OLLS. The intraoperative mean blood loss, mean length of ICU stay, mean hospital stay were significantly increased in the OLLS group (p < 0.05). Complications were assessed according to the Clavien-Dindo classification. The incidence of grade I-II complications was similar between the two groups. The incidence of grade III-V complications was increased in the OLLS group (p = 0.008). The mean perioperative cost was similar between the two techniques. Conclusion: These outcomes for left lateral sectionectomy suggest that both approaches are feasible and safe. However, the results should be treated with caution given the small number of the included randomized controlled studies and potential for selection bias between the two techniques. © 2018 International Hepato-Pancreato-Biliary Association Inc
Validation of the Surgical Outcome Risk Tool (SORT) for Predicting Postoperative Mortality in Colorectal Cancer Patients Undergoing Surgery and Subgroup Analysis
Background: The accurate evaluation of perioperative risk is crucial to facilitate the shared decision-making process. Surgical outcome risk tool (SORT) has been developed to provide enhanced and more feasible identification of high-risk surgical patients. Nonetheless, SORT has not been validated for patients with colorectal cancer undergoing surgery. Our aim was to determine whether SORT can accurately predict mortality after surgery for colorectal cancer and to compare it with traditional risk models. Method: 526 patients undergoing surgery performed by a colorectal surgical team in a single Greek tertiary hospital (2011–2019) were included. Five risk models were evaluated: (1) SORT, (2) Physiology and Operative Severity Score for the enumeration of Mortality and Morbidity (POSSUM), (3) Portsmouth POSSUM (P-POSSUM), (4) Colorectal POSSUM (CR-POSSUM), and (5) the Association of Great Britain and Ireland (ACPGBI) score. Model accuracy was assessed by observed to expected (O:E) ratios, and area under Receiver Operating Characteristic curve (AUC). Results: Ten patients (1.9%) died within 30 days of surgery. SORT was associated with an excellent level of discrimination [AUC:0.81 (95% CI:0.68–0.94); p = 0.001] and provided the best performing calibration of all models in the entire dataset analysis (H–L:2.82; p = 0.83). Nonetheless, SORT underestimated mortality. SORT model demonstrated excellent discrimination and calibration predicting perioperative mortality in patients undergoing (1) open surgery, (2) emergency/acute surgery, and (3) in cases with colon-located cancer. Conclusion: SORT is an easily adopted risk-assessment tool, associated with enhanced accuracy, that could be implemented in the perioperative pathway of patients undergoing surgery for colorectal cancer. © 2021, Société Internationale de Chirurgie